Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Mar 19, 2014 sanofi Beneficial Owner (10% or more) Buy 9,746 326.44 - 328.67
Jan 22, 2008 brown michael s Director Automatic Sell 9,800 25.00
Sep 19, 2008 kolinski stuart Officer Sell 9,992 23.40 - 23.69
Sep 19, 2008 kolinski stuart Officer Option Execute 9,992 8.50
Mar 22, 2010 aberman michael s Officer Acquisition (Non Open Market) 10,000 n/a
Feb 15, 2008 baker charles a Director Automatic Sell 10,000 18.67 - 19.06
Feb 15, 2008 baker charles a Director Option Execute 10,000 7.91
Feb 20, 2009 baker charles a Director Automatic Sell 10,000 18.16
Feb 20, 2009 baker charles a Director Option Execute 10,000 7.66
Nov 5, 2007 brown michael s Director Option Execute 10,000 7.91
May 15, 2013 brown michael s Director Sell 10,000 278.28
Jan 18, 2011 brown michael s Director Option Execute 10,000 15.01 - 18.80
Jan 21, 2009 gilman alfred g Director Option Execute 10,000 7.66
Feb 20, 2008 gilman alfred g Director Option Execute 10,000 7.91
Mar 25, 2014 goldstein joseph l Director Acquisition (Non Open Market) 10,000 n/a
Oct 14, 2011 goldstein joseph l Director Option Execute 10,000 23.84
Mar 15, 2012 goldstein joseph l Director Automatic Sell 10,000 110.77 - 115.00
Mar 15, 2012 goldstein joseph l Director Option Execute 10,000 18.61
Oct 4, 2010 goldstein joseph l Director Option Execute 10,000 18.80
Nov 23, 2010 goldstein joseph l Director Option Execute 10,000 15.01 - 18.80
Showing 401-420 of 863 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)